ISMRM Workshops: Learn, Share Research & Network

ISMRM Workshop on

Cancer Imaging: From Discovery to Diagnosis

New Workshop Dates Announced
02-05 November 2021 • Bahia Resort Hotel, San Diego, CA, USA

Call for Abstracts & Stipend Applications
Coming Soon


Co-Chair: Sungheon Gene Kim, Ph.D.
New York University School of Medicine, New York, NY, USA

Co-Chair: C. Chad Quarles, Ph.D.
Barrow Neurological Institute, Phoenix, AZ, USA

Registration & Travel

Registration Coming Soon
Early Registration Deadline:

Travel Information

Supporters & Declarations

Faculty Declarations Coming August 2021

For Attendees

Program: Scroll Down or Open Separately

Guidelines for Presenters & Posters

Overview & Program

Workshop Overview

This workshop, organized by the ISMRM MR of Cancer Working Group, will focus on the development and application of novel MRI/MRS acquisition and analysis technologies for cancer. At this bi-annual workshop, we will address and highlight strategies for successfully traversing the translational pipeline. Topics will include development and validation of new cancer imaging methods, analysis tools and probes, preclinical application, first-in-human studies, image-guided therapies, clinical trial evaluation, quality assurance and benchmarking, and clinical best practices.

The program will feature invited scientific presentations from a diverse group of experts in technical innovation and clinical practice (physicians and SMRT members), in addition to proffered papers and poster sessions. The Bill Negendank Young Investigator Awards, for which students, trainees, and post-doctoral fellows are eligible, will also be awarded based on the quality of the presented work.

Target Audience: The workshop is designed for basic scientists, physicians, regulators, technologists, students, trainees, and postdoctoral fellows with an interest in cancer MRI/MRS.

Educational Objectives

Upon completion of this activity, participants should be able to:

  • Describe novel cancer imaging methods and contrast mechanisms;
  • Describe advancements in clinical biomarker development;
  • Identify opportunities for image-guided adaptive therapy;
  • Recognize the role and challenges of using machine learning, artificial intelligence and mathematical modeling in cancer imaging applications;
  • Explain the role of quality assurance, standardization and benchmarking in clinical cancer imaging; and
  • Identify best practices for translation of cancer imaging methods into the clinic.

Preliminary Program

Coming 2021

Back Questions? Contact us at

The International Society for Magnetic Resonance in Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.